Most cited papers in Cancer Research and Treatments
What are the most cited papers in Cancer Research and Treatments?
The most cited paper in Cancer Research and Treatments is "Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma" (Roger Stupp, Warren P. Mason, Martin J. van den Bent et al., 2005), with 22,109 citations. Next come "Hallmarks of Cancer: New Dimensions" (9,794) and "Microenvironmental regulation of tumor progression and metastasis" (8,290).
Showing 50 of 100 papers. Every paper with more than 1,547 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren P. Mason, Martin J. van den Bent et al. · New England Journal of Medicine | 9 Mar 2005 | 22,109 |
| 2 | Hallmarks of Cancer: New Dimensions Douglas Hanahan · Cancer Discovery | 2022 | 9,794 |
| 3 | Microenvironmental regulation of tumor progression and metastasis Daniela F. Quail, Johanna A. Joyce · Nature Medicine | Nov 2013 | 8,290 |
| 4 | Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Roger Stupp et al. · The Lancet Oncology | 10 Mar 2009 | 7,889 |
| 5 | Specific Association of Human Telomerase Activity with Immortal Cells and Cancer Nam W. Kim, Mieczyslaw A. Piatyszek, Karen R. Prowse et al. · Science | 23 Dec 1994 | 7,190 |
| 6 | Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer Edward B. Garon et al. · New England Journal of Medicine | 19 Apr 2015 | 6,312 |
| 7 | Protein production by auto-induction in high-density shaking cultures F. William Studier · Protein Expression and Purification | 8 Feb 2005 | 6,238 |
| 8 | Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy Rakesh K. Jain · Science | 6 Jan 2005 | 5,534 |
| 9 | Cancer Cell Cycles Charles J. Sherr · Science | 6 Dec 1996 | 5,411 |
| 10 | A Perspective on Cancer Cell Metastasis Christine Louise Chaffer, Robert A. Weinberg · Science | 24 Mar 2011 | 4,934 |
| 11 | The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Isaiah J. Fidler · Nature reviews. Cancer | 30 May 2003 | 4,744 |
| 12 | Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Lawrence A. Donehower, Michele Harvey, Betty L. Slagle et al. · Nature | Mar 1992 | 4,702 |
| 13 | Mdm2 promotes the rapid degradation of p53 Ygal Haupt, Ruth Ben-Yakar Maya, Anat Kazaz et al. · Nature | May 1997 | 4,575 |
| 14 | The biology and function of fibroblasts in cancer Raghu K. Kalluri · Nature reviews. Cancer | 23 Aug 2016 | 4,462 |
| 15 | Tumor Metastasis: Molecular Insights and Evolving Paradigms Scott Valastyan, Robert A. Weinberg · Cell | Oct 2011 | 4,179 |
| 16 | A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Catherine Adell O'Brien, Aaron F. Pollett, Steven Gallinger et al. · Nature | 19 Nov 2006 | 4,107 |
| 17 | Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Toshiyuki Miyashita, John C. Reed · Cell | 1995 | 4,079 |
| 18 | Amino Acid Metabolism in Mammalian Cell Cultures Harry Eagle · Science | 21 Aug 1959 | 4,032 |
| 19 | Identification and expansion of human colon-cancer-initiating cells Lucia Ricci‐Vitiani, Dario Giuseppe Lombardi, Emanuela Pilozzi et al. · Nature | 19 Nov 2006 | 4,008 |
| 20 | Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium Toshiro Sato, Daniel E. Stange, Marc Ferrante et al. · Gastroenterology | 3 Sep 2011 | 3,882 |
| 21 | Microenvironmental regulation of metastasis Johanna A. Joyce, Jeffrey W. Pollard · Nature reviews. Cancer | 12 Mar 2008 | 3,730 |
| 22 | Clinical development and potential of photothermal and photodynamic therapies for cancer Xingshu Li, Jonathan F. Lovell, Juyoung Yoon et al. · Nature Reviews Clinical Oncology | 22 Jul 2020 | 3,467 |
| 23 | Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Walter Stummer, Uwe Pichlmeier, Thomas R. Meinel et al. · The Lancet Oncology | 13 Apr 2006 | 3,416 |
| 24 | p21 is a universal inhibitor of cyclin kinases Yue Xiong, Gregory James Hannon, Hui Zhang et al. · Nature | Dec 1993 | 3,400 |
| 25 | Pembrolizumab for Early Triple-Negative Breast Cancer Peter Schmid et al. · New England Journal of Medicine | 26 Feb 2020 | 3,298 |
| 26 | Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Anne P. Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute | 5 Jun 1991 | 3,295 |
| 27 | Emerging Biological Principles of Metastasis Arthur W. Lambert, Diwakar Ram Pattabiraman, Robert A. Weinberg · Cell | Feb 2017 | 3,223 |
| 28 | Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J L Cordell, Brunangelo Falini, Wendy N. Erber et al. · Journal of Histochemistry & Cytochemistry | Feb 1984 | 3,212 |
| 29 | Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene Michael E. Greenberg, Edward Benjamin Ziff · Nature | Oct 1984 | 3,188 |
| 30 | The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Jamil Antonio Momand, Gerard P. Zambetti, David C. Olson et al. · Cell | Jun 1992 | 3,151 |
| 31 | p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Scott W. Lowe, H. Earl Ruley, Tyler Jacks et al. · Cell | Sep 1993 | 2,949 |
| 32 | p53 is required for radiation-induced apoptosis in mouse thymocytes Scott W. Lowe, Earlene M. Schmitt, Sallie W. Smith et al. · Nature | Apr 1993 | 2,903 |
| 33 | Exploiting tumour hypoxia in cancer treatment J. Martin Brown, William Robert Wilson · Nature reviews. Cancer | Jun 2004 | 2,847 |
| 34 | A survey of telomerase activity in human cancer Jerry W. Shay, Silvia Bacchetti · European Journal of Cancer | Apr 1997 | 2,806 |
| 35 | Mutations in the p53 gene occur in diverse human tumour types Janice M. Nigro, Suzanne J. Baker, Antonette C. Preisinger et al. · Nature | Dec 1989 | 2,777 |
| 36 | Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects Michael Höckel, Peter W. Vaupel · JNCI Journal of the National Cancer Institute | 21 Feb 2001 | 2,680 |
| 37 | Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma Robert H.I. Andtbacka et al. · Journal of Clinical Oncology | 27 May 2015 | 2,662 |
| 38 | The human tumor microbiome is composed of tumor type–specific intracellular bacteria Deborah Nejman et al. · Science | 28 May 2020 | 2,523 |
| 39 | Production of large amounts of hydrogen peroxide by human tumor cells. Ted P. Szatrowski, Carl Nathan · PubMed | Feb 1991 | 2,519 |
| 40 | A model for p53-induced apoptosis Kornélia Polyák, Yong Xia, Jay Louis Zweier et al. · Nature | Sep 1997 | 2,514 |
| 41 | Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Wen Xue, Lars Zender, Cornelius Miething et al. · Nature | 24 Jan 2007 | 2,483 |
| 42 | Molecular principles of metastasis: a hallmark of cancer revisited Jawad Fares, Mohamad Y. Fares, Hussein H. Khachfe et al. · Signal Transduction and Targeted Therapy | 12 Mar 2020 | 2,454 |
| 43 | Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer Robert Allen Burger, Mark F. Brady, Michael A. Bookman et al. · New England Journal of Medicine | 28 Dec 2011 | 2,422 |
| 44 | Creation of human tumour cells with defined genetic elements William C. Hahn, Christopher M. Counter, Ante S. Lundberg et al. · Nature | 29 Jul 1999 | 2,366 |
| 45 | p53: puzzle and paradigm. L J Ko, Carol L. Prives · Genes & Development | May 1996 | 2,357 |
| 46 | In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2 Donald J. Giard, Stuart A. Aaronson, George J. Todaro et al. · JNCI Journal of the National Cancer Institute | Nov 1973 | 2,340 |
| 47 | Thymocyte apoptosis induced by p53-dependent and independent pathways Alan Richard Clarke, Colin A. Purdie, David James Harrison et al. · Nature | Apr 1993 | 2,300 |
| 48 | p53 in health and disease Karen H. Vousden, David Philip Lane · Nature Reviews Molecular Cell Biology | 23 Mar 2007 | 2,281 |
| 49 | Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain Paul H. Kussie, Svetlana S. Gorina, Vincent Maréchal et al. · Science | 8 Nov 1996 | 2,246 |
| 50 | Safety and antitumor activity of recombinant soluble Apo2 ligand Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation | 15 Jul 1999 | 2,234 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.